130 related articles for article (PubMed ID: 16571898)
1. Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.
Liedert B; Pluim D; Schellens J; Thomale J
Nucleic Acids Res; 2006 Mar; 34(6):e47. PubMed ID: 16571898
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-DNA adduct repair of transcribed genes is controlled by two circadian programs in mouse tissues.
Yang Y; Adebali O; Wu G; Selby CP; Chiou YY; Rashid N; Hu J; Hogenesch JB; Sancar A
Proc Natl Acad Sci U S A; 2018 May; 115(21):E4777-E4785. PubMed ID: 29735688
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-induced DNA crosslinks trigger neurotoxicity in C. elegans.
Wynen F; Krautstrunk J; Müller LM; Graf V; Brinkmann V; Fritz G
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119591. PubMed ID: 37730131
[TBL] [Abstract][Full Text] [Related]
4. Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale.
Shu X; Xiong X; Song J; He C; Yi C
Angew Chem Int Ed Engl; 2016 Nov; 55(46):14246-14249. PubMed ID: 27736024
[TBL] [Abstract][Full Text] [Related]
5. HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells.
Ewers KM; Patil S; Kopp W; Thomale J; Quilitz T; Magerhans A; Wang X; Hessmann E; Dobbelstein M
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944784
[TBL] [Abstract][Full Text] [Related]
6. History and emerging trends in chemotherapy for gastric cancer.
Yamashita K; Hosoda K; Niihara M; Hiki N
Ann Gastroenterol Surg; 2021 Jul; 5(4):446-456. PubMed ID: 34337293
[TBL] [Abstract][Full Text] [Related]
7. Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer.
Dilly AK; Honick BD; Frederick R; Elapavaluru A; Velankar S; Makala H; Hitchens TK; Foley LM; Guo J; Beumer JH; Rigatti LH; Lee YJ; Bartlett DL; Choudry HA
Transl Res; 2021 Mar; 229():100-114. PubMed ID: 33164812
[TBL] [Abstract][Full Text] [Related]
8. Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells.
Böckelmann L; Starzonek C; Niehoff AC; Karst U; Thomale J; Schlüter H; Bokemeyer C; Aigner A; Schumacher U
Histochem Cell Biol; 2020 May; 153(5):367-377. PubMed ID: 32125512
[TBL] [Abstract][Full Text] [Related]
9. Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells.
Melnikova M; Wauer US; Mendus D; Hilger RA; Oliver TG; Mercer K; Gohlke BO; Erdmann K; Niederacher D; Neubauer H; Buderath P; Wimberger P; Kuhlmann JD; Thomale J
Mol Oncol; 2020 Apr; 14(4):686-703. PubMed ID: 32037720
[TBL] [Abstract][Full Text] [Related]
10. Long-term, genome-wide kinetic analysis of the effect of the circadian clock and transcription on the repair of cisplatin-DNA adducts in the mouse liver.
Yang Y; Liu Z; Selby CP; Sancar A
J Biol Chem; 2019 Aug; 294(32):11960-11968. PubMed ID: 31217280
[TBL] [Abstract][Full Text] [Related]
11. Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs.
Yimit A; Adebali O; Sancar A; Jiang Y
Nat Commun; 2019 Jan; 10(1):309. PubMed ID: 30659176
[TBL] [Abstract][Full Text] [Related]
12. Imaging cellular responses to antigen tagged DNA damage.
Bellani MA; Huang J; Paramasivam M; Pokharel D; Gichimu J; Zhang J; Seidman MM
DNA Repair (Amst); 2018 Nov; 71():183-189. PubMed ID: 30166246
[TBL] [Abstract][Full Text] [Related]
13. ELISA-like Analysis of Cisplatinated DNA Using Magnetic Separation.
Smerkova K; Vlcnovska M; Dostalova S; Milosavljevic V; Kopel P; Vaculovic T; Krizkova S; Vaculovicova M; Adam V; Kizek R
Nanobiomedicine (Rij); 2015; 2():10. PubMed ID: 29942374
[TBL] [Abstract][Full Text] [Related]
14. The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models.
Dakup PP; Porter KI; Little AA; Gajula RP; Zhang H; Skornyakov E; Kemp MG; Van Dongen HPA; Gaddameedhi S
Oncotarget; 2018 Mar; 9(18):14524-14538. PubMed ID: 29581861
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines.
Skowron MA; Melnikova M; van Roermund JGH; Romano A; Albers P; Thomale J; Schulz WA; Niegisch G; Hoffmann MJ
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462944
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin alters the function and expression of N-type voltage-gated calcium channels in the absence of morphological damage of sensory neurons.
Leo M; Schmitt LI; Jastrow H; Thomale J; Kleinschnitz C; Hagenacker T
Mol Pain; 2017; 13():1744806917746565. PubMed ID: 29166837
[TBL] [Abstract][Full Text] [Related]
17. Sequence-Independent DNA Nanogel as a Potential Drug Carrier.
Zhang W; Tung CH
Macromol Rapid Commun; 2017 Oct; 38(20):. PubMed ID: 28895266
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.
Bartelink IH; Prideaux B; Krings G; Wilmes L; Lee PRE; Bo P; Hann B; Coppé JP; Heditsian D; Swigart-Brown L; Jones EF; Magnitsky S; Keizer RJ; de Vries N; Rosing H; Pawlowska N; Thomas S; Dhawan M; Aggarwal R; Munster PN; Esserman LJ; Ruan W; Wu AHB; Yee D; Dartois V; Savic RM; Wolf DM; van 't Veer L
Breast Cancer Res; 2017 Sep; 19(1):107. PubMed ID: 28893315
[TBL] [Abstract][Full Text] [Related]
19. ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.
Owczarek TB; Kobayashi T; Ramirez R; Rong L; Puzio-Kuter AM; Iyer G; Teo MY; Sánchez-Vega F; Wang J; Schultz N; Zheng T; Solit DB; Al-Ahmadie HA; Abate-Shen C
Cancer Res; 2017 Feb; 77(4):1035-1046. PubMed ID: 28082400
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin.
Alvarez-Berríos MP; Vivero-Escoto JL
Int J Nanomedicine; 2016; 11():6251-6265. PubMed ID: 27920531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
